Financial Disclosure by Clinical Investigators

ICR 200301-0910-001

OMB: 0910-0396

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
IC ID
Document
Title
Status
6056 Migrated
ICR Details
0910-0396 200301-0910-001
Historical Active 200207-0910-001
HHS/FDA
Financial Disclosure by Clinical Investigators
Reinstatement with change of a previously approved collection   No
Regular
Approved without change 02/07/2003
Retrieve Notice of Action (NOA) 01/02/2003
Approved consistent with changes made since the last submission and withdrawal.
  Inventory as of this Action Requested Previously Approved
04/30/2006 04/30/2006
1 0 0
18,750 0 0
0 0 0

The collection requires sponsors of any drug, biologic or device marketing application to certify to the absence of clinical investigators and/or disclose those financial interest as required, when covered studies are submitted to FDA in support of product marketing.

None
None


No

1
IC Title Form No. Form Name
Financial Disclosure by Clinical Investigators 3454, 3455

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1 0 0 1 0 0
Annual Time Burden (Hours) 18,750 0 0 18,750 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/02/2003


© 2024 OMB.report | Privacy Policy